Review and assessment, more than a year overdue, includes data on licensing, market saturation, sales, and more stretching back seven years
“Rather than creating complicated legal and regulatory structures for psilocybin, the best path forward may be clearing the way for education.”
Assessing their effectiveness presents unique challenges, particularly within the rigorous framework of double-blind trials
New research suggests that in some states, medicinal cannabis use could be leading to a reduction in the use of anxiety medications
Massachusetts cannabis stakeholders say new CCC action is a small step toward stopping laboratory fraud, but nonetheless movement in the right direction
The results of this study “ought to be reassuring to older adults who are increasingly turning to cannabis to manage age-related symptoms like chronic pain.”
The Massachusetts Cannabis Control Commission is considering changes to improve laboratory integrity and prevent fraud. But stakeholders say the agency is missing the big picture.
“I am hopeful this is a first step towards Massachusetts someday being positioned as a global leader in cannabis research.”
Observational studies have previously reported decreases in consumers’ alcohol use on days when they use cannabis
“The continued criminalization of cannabis only compounds the public safety risks that the unregulated marketplace poses to young people and others.”
